SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹41,238 Cr | ₹34,400 Cr | ₹26,449 Cr | ₹19,956 Cr | ₹17,656 Cr |
What is the latest Net Current Assets ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹41,238 Cr |
| Mar2025 | ₹34,400 Cr |
| Mar2024 | ₹26,449 Cr |
| Mar2023 | ₹19,956 Cr |
| Mar2022 | ₹17,656 Cr |
How is Net Current Assets of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹41,238 Cr | 19.88 | |
| Mar2025 | ₹34,400 Cr | 30.06 | |
| Mar2024 | ₹26,449 Cr | 32.54 | |
| Mar2023 | ₹19,956 Cr | 13.02 | |
| Mar2022 | ₹17,656 Cr | - | |
Compare Net Current Assets of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,623.6 Cr | -2.6% | 2.4% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 6.5% | 23.3% | 25.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,108.0 Cr | 2.6% | 3% | 33.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.1% | -0.2% | -7.9% | Stock Analytics | |
| MANKIND PHARMA | ₹101,267.0 Cr | -4.9% | -3.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 2.6% | -13.3% | -10.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -2.6% |
2.4% |
14.6% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses